# Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide

> **NCT00162760** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 19 (—)

## Conditions studied

- Idiopathic Pulmonary Fibrosis (IPF)

## Interventions

- **DRUG:** Thalidomide

## Key facts

- **NCT ID:** NCT00162760
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 19 (—)
- **Last updated:** 2010-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00162760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00162760, "Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00162760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*